SAN FRANCISCO, Jan. 18, 2022 /PRNewswire/ -- Today, Healthline Media is launching a suite of seven health condition communities through its new...
Phonak Lyric™, the 100% Invisible Hearing Aid, is Clinically Proven to Provide Relief of TinnitusSTÄFA, SWITZERLAND / ACCESSWIRE / January...
DOYLESTOWN, PA / ACCESSWIRE / January 18, 2022 / Neuropathix, Inc. ("Neuropathix" or the "Company") (OTCQB:NPTX), a socially responsible pain...
"Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the...
LOS ANGELES CA / ACCESSWIRE / January 18, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions...
Formerly served as VP of Finance and Commercial Operations at Biogen with 20+ years of business and strategic financial leadership...
LOS ANGELES, CA / ACCESSWIRE / January 18, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), a...
FDA's Fast Track Designation for the pan-PI3K/mTOR inhibitor highlights potential to address the urgent need for new treatment options for...
KATY, TX / ACCESSWIRE / January 18, 2022 / Neutra Corp. (OTC PINK:NTRR) continues plans for Phase-1 clinical trials regarding...
ORLANDO, FL / ACCESSWIRE / January 18, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced an expanded product development pipeline for its...
1933 Industries Signs Binding Letter of Intent to Acquire Beverage Company Day OneVANCOUVER, BC / ACCESSWIRE / January 18, 2022...
TORONTO, ON / ACCESSWIRE / January 18, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) ("NuGen M.D." or the "Company") is...
WOBURN, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell® technology has received...
Company identifies unique two-part extraction and transdermal delivery processVANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp....
All-cause mortality is 50% more likely during this common diabetes complicationSOMERVILLE, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Podimetrics, a...
First-of-its-kind platform provides a turnkey solution to reduce costs and increase access to testingSAN MATEO, Calif., Jan. 18, 2022 (GLOBE...
New huNOG-EXL EA Model Extends Study Windows SignificantlyRENSSELAER, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader...
Brazil Phase 2 Pulmonary Long-Hauler clinical trial of COVI-MSC is now authorized to proceed.The study will compare therapy using mesenchymal...
Strong enrollment within multi-cohort TRIDENT-1 Phase 2 registration enabling study of repotrectinib; completion of targeted 60 patients within EXP-4 ROS1+...
PRAX-562 demonstrated robust preclinical antiseizure activity and exhibited an improved preclinical tolerability profile compared to standard-of-care Praxis expects to initiate...